FDA/CDC

FDA: Recall of select EpiPen products

Publish date: April 1, 2017
By
Lucas Franki

 

Meridian Medical Technologies has issued a voluntary recall for 13 lots of EpiPen products, according to a press release from the U.S. Food and Drug Administration.

The voluntary recall includes EpiPen and EpiPen Jr. Auto-Injector distributed between Dec. 17, 2015, and July 1, 2016 by Mylan Specialty. Products included in the recall may contain a defective part which would prevent the device from activating.

“While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated,” the FDA said in the press release.

Consumers who need their EpiPens should keep them until a they obtain a replacement, the FDA recommended.

Find the full press release on the FDA website.

Next Article:

Oral agent found promising for subset of chronic rhinosinusitis patients

Related Articles